Showing results (1631-1640 of 2,551) with videos related to

Sort By:
Pageof 256
European Journal of Applied Physiology|October 27, 2014
Once-weekly muscle endurance and strength training prevents deterioration of muscle oxidative function and attenuates the degree of strength decline during 3-week forearm immobilizationToshiyuki Homma, Takafumi Hamaoka, Takuya Osada, et al.
Brain Tumor Pathology|August 24, 2017
Encouraging option of multi-staged gross total resection for a C11orf-RelA fusion-positive supratentorial anaplastic ependymomaTaishi Nakamura, Kohei Fukuoka, Junji Ikeda, et al.
Clinical Case Reports|July 1, 2021
Successful management of therapy-related chronic myelomonocytic leukemia with cytarabine, aclarubicin, and azacitidine following tegafur/gimeracil/oteracilSoichiro Nakako, Teruhito Takakuwa, Hirona Ichimura, et al.
The Journal of Investigative Dermatology|November 26, 2020
IFN-γ-Stimulated Apoptotic Keratinocytes Promote Sclerodermatous Changes in Chronic Graft-Versus-Host DiseaseAkimasa Saito, Yuki Ichimura, Noriko Kubota, et al.
Anatomical Science International|January 16, 2021
Anatomic characterization of the tibial and fibular nutrient arteries in humansHidaka Anetai, Shota Kinose, Riku Sakamoto, et al.
Biocontrol Science|March 15, 2021
Sodium Hypochlorite is Effective against Biofilms in Dialysis EquipmentEiichi Osono, Kazumi Honda, Yuki Inoue, et al.
BMC Pulmonary Medicine|April 1, 2021
Response to pembrolizumab in a patient with primary lung adenocarcinoma originated from indium lungYasuharu Sekine, Hideo Ichimura, Sho Ueda, et al.
Brain Tumor Pathology|July 14, 2012
Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation statusMakoto Ohno, Yoshitaka Narita, Yasuji Miyakita, et al.
Oncology Letters|June 29, 2012
Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsiesTsuyoshi Ueno, Junichi Soh, Takao Hiraki, et al.
International Journal of Oncology|July 25, 2012
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapyYoshiko Okita, Yoshitaka Narita, Yasuji Miyakita, et al.
Pageof 256